OncoSec Medical reports 2018 executive compensation

CEO Daniel J. O'Connor receives $4.2M

OncoSec Medical reported fiscal year 2018 executive compensation information on November 8, 2018.

In 2018, four executives at OncoSec Medical received on average a compensation package of $2,175,181, a 202% increase compared to previous year.

Average pay of disclosed executives at OncoSec Medical

Daniel J. O'Connor, Chief Executive Officer, received $4,191,583 in total. 91.11% of O'Connor's compensation, or $3,819,000, was in option awards. O'Connor also received $70,136 in bonus, $283,078 in salary, as well as $19,369 in other compensation.

Punit Dhillon, Chief Executive Officer, received a compensation package of $2,674,895, which increased by 234% compared to previous year. 36.72% of the compensation package, or $982,295, was in other compensation.

Sara Bonstein, Chief Financial Officer, earned $919,231 in 2018.

Richard Slansky, Chief Financial Officer, received $915,014 in 2018, which increases by 76% compared to 2017.

OncoSec Medical's fiscal year ends on July 31.